Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-31

Clinical Trial Update: Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. [Phase 2]

View source ↗

Summary

Phase 2 study of PF-00446687 in post-menopausal women with female sexual dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-00446687

Snippet

Sponsor: Pfizer | Conditions: Female Sexual Dysfunction | Phase 2 | Status: COMPLETED